Breaking News

Selvita, Chiesi Extend Chemistry Collaboration

By Kristin Brooks | January 10, 2014

Partnership’s success evolves in support of Chiesi pipeline

Selvita, a drug discovery provider based in Poland, has extended its chemistry research collaboration with Chiesi Farmaceutici in Italy. The companies entered a fee-for-service chemical synthesis collaboration in 2011, which became an FTE-based alliance in 2012-2013, following the successful completion of several projects. The collaboration supports Chiesi’s drug discovery and development pipeline focused on respiratory, cardiovascular and special care disorders.
 
“We are very proud to be working for such renowned and innovative company as Chiesi. Chiesi projects always involve novel, challenging chemistry and they let us demonstrate the full potential of Selvita’s chemistry team, our broad knowledge, experience and skills.” said Dr. Miroslawa Zydron, director of Contract Chemistry Department at Selvita.

Related Contract Manufacturing:

blog comments powered by Disqus
  • FDA & Drug Development

    FDA & Drug Development

    Rachelle Du2019Souza, Regulatory Heights Inc.||September 8, 2016
    You must perform the necessary due diligence to stay on top of regulatory developments

  • The Role of Alliances in Modern Drug Development

    The Role of Alliances in Modern Drug Development

    Dr. Claire Madden-Smith, Senior Vice President, Juniper Pharma Services||September 8, 2016
    Combining expertise to get drug candidates through development

  • Limiting APIs in Manufacturing Effluent

    Limiting APIs in Manufacturing Effluent

    Joan Tell, Robert Drinane, Bruce Naumann, Jessica Vestel, and Gregory Gagliano, Merck & Co., Inc.||June 2, 2016
    An approach for setting limits on pharmaceuticals discharged in manufacturing effluent